Back

Association of cognitive impairment with dyslipidemia in patients with atrial fibrillation: preliminary results from a prospective registry

13 April 2026 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: Risk factor management in atrial fibrillation Cognitive Function and Autonomy in Patients with Atrial Fibrillation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sanghamitra Mohanty

St. David's Medical Center, Austin (United States of America)

5 More presentations in this session

Presentation thumbnail
Change in sleep apnea parameters in patients with atrial fibrillation undergoing pulmonary vein isolation: interim analysis of the AAHIi study
Doctor P. Basiukiewicz (Grodzisk Mazowiecki, PL)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors and the risk of atrial fibrillation recurrence within one year after radiofrequency ablation
Doctor M. Velescu (Cluj Napoca, RO)
Abstract Slides Video
Presentation thumbnail
Improvement in the severity of sleep disordered breathing three months after pulmonary vein isolation in patients with persistent atrial fibrillation
Assistant Professor Y. Naruse (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Impact of mobile health-detected airflow obstruction on periprocedural symptom severity and quality of life in patients with atrial fibrillation undergoing first-time ablation.
Ms K. Ignaczak (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Optimized concomitant rhythm and ischemia management in patients with atrial fibrillation and coronary artery disease
Doctor J. Dickow (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factor management in atrial fibrillation

The Event

Event poster

EHRA 2026

13 April 2026 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Cognitive patterns according to mini-mental state examination domains in patients with AF and association with all-cause mortality: a cluster analysis from a contemporary prospective study
thumbnail
Congress Presentation
Changes in Cognitive Function in Patients with Subclinical Atrial Fibrillation Treated with Apixaban or Aspirin: A Sub-Study from the ARTESiA Trial
thumbnail
Congress Presentation
Biomarkers for the prediction of cognitive decline in atrial fibrillation patients

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources